The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. That said, here are two stocks where Wall Street’s excitement appears well-founded and one where consensus estimates seem disconnected from reality.
One Stock to Sell:
Everforth (EFOR)
Consensus Price Target: $29.33 (42.3% implied return)
Evolving from its roots in IT staffing to become a high-end technology consulting powerhouse, Everforth (EFOR) provides specialized IT consulting services and staffing solutions to Fortune 1000 companies and U.S. federal government agencies.
Why Do We Avoid EFOR?
- Annual sales declines of 4.6% for the past two years show its products and services struggled to connect with the market during this cycle
- Estimated sales for the next 12 months are flat and imply a softer demand environment
- Earnings per share have dipped by 2.5% annually over the past five years, which is concerning because stock prices follow EPS over the long term
Everforth’s stock price of $20.61 implies a valuation ratio of 5.5x forward P/E. Read our free research report to see why you should think twice about including EFOR in your portfolio.
Two Stocks to Buy:
Houlihan Lokey (HLI)
Consensus Price Target: $172.50 (24.7% implied return)
Founded in 1972 and known for its expertise in complex financial situations, Houlihan Lokey (NYSE: HLI) is a global investment bank specializing in mergers and acquisitions, capital markets, financial restructurings, and valuation advisory services.
Why Should You Buy HLI?
- Impressive 16.9% annual revenue growth over the last two years indicates it’s winning market share this cycle
- Incremental sales over the last two years have been highly profitable as its earnings per share increased by 29.7% annually, topping its revenue gains
- Annual tangible book value per share growth of 20.1% over the past two years was outstanding, reflecting strong capital accumulation this cycle
At $138.29 per share, Houlihan Lokey trades at 16.8x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
ConocoPhillips (COP)
Consensus Price Target: $142.77 (21.9% implied return)
Operating the famous Prudhoe Bay field discovered in 1968 that transformed Alaska's economy, ConocoPhillips (NYSE: COP) explores for and produces crude oil, natural gas, and liquefied natural gas across North America, Europe, Asia, and Africa.
Why Will COP Beat the Market?
- Annual revenue growth of 8% over the past ten years was outstanding, reflecting market share gains this cycle
- Dominant market position is represented by its $60.5 billion in revenue and gives it fixed cost leverage when sales grow
- Robust free cash flow margin of 17.3% gives it many options for capital deployment
ConocoPhillips is trading at $117.16 per share, or 11.4x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
